(19)
(11) EP 4 824 100 A2

(12)

(88) Date of publication A3:
14.08.2025

(43) Date of publication:
21.10.2026 Bulletin 2026/43

(21) Application number: 24904826.5

(22) Date of filing: 11.12.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61P 35/00(2006.01)
A61K 47/68(2017.01)
A61K 39/395(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 47/6849; A61K 47/6851; A61K 47/68031; A61K 47/6889; A61P 35/00
(86) International application number:
PCT/US2024/059633
(87) International publication number:
WO 2025/128735 (19.06.2025 Gazette 2025/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 11.12.2023 US 202363608714 P

(71) Applicants:
  • Nextcure, Inc.
    Beltsville, MD 20705 (US)
  • LigaChem Biosciences, Inc.
    Daejeon (KR)

(72) Inventors:
  • FITZGERALD, Daniel P.
    Beltsville, Maryland 20705 (US)
  • FLIES, Dallas Benjamin
    Beltsville, Maryland 20705 (US)
  • LANGERMANN, Solomon
    Beltsville, Maryland 20705 (US)
  • JUNG, Kwang Hwa
    Daejeon (KR)
  • OH, Hwanhee
    Daejeon (KR)
  • CHUNG, Chul-Woong
    Daejeon (KR)
  • SONG, Ho Young
    Daejeon (KR)
  • KANG, Myungji
    Daejeon (KR)

(74) Representative: D Young & Co LLP 
3 Noble Street
London EC2V 7BQ
London EC2V 7BQ (GB)

   


(54) B7-H4 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF